Resource Treatment Updates From new drug treatments being approved or starting drug trials to an improved understanding of the drugs already existing as treatments in RA and the optimal ways of using these drugs to treat the condition, our drug updates will help to inform patients of the latest information on RA drugs. Print Since the advent of the first biological drugs in RA in the late 1990s, there has been a huge amount of research into new medications. This century has already seen a number of new biologic drugs, as well as biosimilars of the early biologics as they have come out of their patents. We have also seen the emergence of the JAK inhibitors, which offer another form of drug treatment, working differently to biologic drugs and available to take as a tablet, rather than by injection or infusion.From new drug treatments being approved or starting drug trials to an improved understanding of the drugs already existing as treatments in RA and the optimal ways of using these drugs to treat the condition, our drug updates will help to inform patients of the latest information on RA drugs. Medicines in rheumatoid arthritis We believe it is essential that people living with RA understand why certain medicines are used, when they are used and how they work to manage the condition. Order/Download Article Study finds RA drug has no placental transfer in pregnancy A study in Paris has shown that the biologic anti-TNF drug certolizumab pegol does not cross the placenta and is therefore not present in the blood of newborn infants. Article Chronotherapy: The science of timing drugs to our body clock Patients with RA commonly find their symptoms worse in the morning. Doctors are now beginning to think that this is not simply because the joints stiffen up overnight through lack of use. Article Co-Proxamol The licence for co-proxamol was withdrawn in 2007, but for a small number of patients already taking the drug and who did not respond well to a suitable alternative, it continues to be prescribed on a named patient basis. Read more Latest research updates → Research gives us a better understanding of what causes RA, how best to treat and manage the condition and hopefully one day how it might be cured.
Medicines in rheumatoid arthritis We believe it is essential that people living with RA understand why certain medicines are used, when they are used and how they work to manage the condition. Order/Download
Article Study finds RA drug has no placental transfer in pregnancy A study in Paris has shown that the biologic anti-TNF drug certolizumab pegol does not cross the placenta and is therefore not present in the blood of newborn infants.
Article Study finds RA drug has no placental transfer in pregnancy A study in Paris has shown that the biologic anti-TNF drug certolizumab pegol does not cross the placenta and is therefore not present in the blood of newborn infants.
Article Chronotherapy: The science of timing drugs to our body clock Patients with RA commonly find their symptoms worse in the morning. Doctors are now beginning to think that this is not simply because the joints stiffen up overnight through lack of use.
Article Chronotherapy: The science of timing drugs to our body clock Patients with RA commonly find their symptoms worse in the morning. Doctors are now beginning to think that this is not simply because the joints stiffen up overnight through lack of use.
Article Co-Proxamol The licence for co-proxamol was withdrawn in 2007, but for a small number of patients already taking the drug and who did not respond well to a suitable alternative, it continues to be prescribed on a named patient basis.
Article Co-Proxamol The licence for co-proxamol was withdrawn in 2007, but for a small number of patients already taking the drug and who did not respond well to a suitable alternative, it continues to be prescribed on a named patient basis.
Read more Latest research updates → Research gives us a better understanding of what causes RA, how best to treat and manage the condition and hopefully one day how it might be cured.